REG-O3, the innovative therapeutic treatment for Osteoarthritis will be tested in Liège !:

Artialis, specialist in the study of the musculoskeletal disorders and Regulaxis, an innovative French company in the treatment of osteoarthritis, announce today the signing of a 1.6 million euros contract for the preclinical and clinical development of a new molecule, Reg-O3, allowing the repair of cartilage.

Simoultaneous announcement in Paris, France and Liège, Belgium [June 25], 2018